 Jeanne Zenge
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 9 | 2025 | 293 | 1.020 |
Why?
| | Intubation, Intratracheal | 8 | 2022 | 327 | 0.930 |
Why?
| | Telemedicine | 3 | 2023 | 967 | 0.530 |
Why?
| | Infant, Newborn | 16 | 2025 | 6465 | 0.350 |
Why?
| | Pulmonary Circulation | 3 | 2002 | 430 | 0.220 |
Why?
| | Mycoses | 1 | 2025 | 88 | 0.210 |
Why?
| | Registries | 7 | 2022 | 2410 | 0.210 |
Why?
| | Blood Culture | 1 | 2024 | 27 | 0.200 |
Why?
| | Bacterial Infections | 1 | 2025 | 247 | 0.190 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 210 | 0.190 |
Why?
| | Cross Infection | 1 | 2025 | 260 | 0.180 |
Why?
| | Patient Handoff | 1 | 2023 | 44 | 0.180 |
Why?
| | Clinical Competence | 3 | 2019 | 1247 | 0.180 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 13 | 0.180 |
Why?
| | Perinatal Care | 1 | 2022 | 59 | 0.180 |
Why?
| | Laryngoscopes | 1 | 2022 | 45 | 0.180 |
Why?
| | Bacteremia | 1 | 2024 | 222 | 0.170 |
Why?
| | Cyclic GMP | 1 | 2001 | 90 | 0.170 |
Why?
| | Prostaglandins | 1 | 2001 | 94 | 0.170 |
Why?
| | Oxygen | 2 | 2022 | 981 | 0.150 |
Why?
| | Fetal Diseases | 2 | 2020 | 194 | 0.150 |
Why?
| | Hemodynamics | 4 | 2002 | 1118 | 0.140 |
Why?
| | Intensive Care, Neonatal | 1 | 2018 | 43 | 0.140 |
Why?
| | Internationality | 1 | 2018 | 156 | 0.130 |
Why?
| | Emergencies | 1 | 2019 | 174 | 0.130 |
Why?
| | Nitric Oxide | 2 | 2002 | 892 | 0.130 |
Why?
| | Family | 1 | 2021 | 685 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2002 | 777 | 0.110 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 354 | 0.110 |
Why?
| | Lung | 3 | 2002 | 4116 | 0.100 |
Why?
| | Vasodilation | 3 | 2002 | 521 | 0.100 |
Why?
| | Patient Care Team | 1 | 2019 | 697 | 0.100 |
Why?
| | Sheep | 5 | 2002 | 876 | 0.090 |
Why?
| | Endothelial Growth Factors | 2 | 2002 | 62 | 0.090 |
Why?
| | Lymphokines | 2 | 2002 | 128 | 0.090 |
Why?
| | Physicians | 1 | 2021 | 956 | 0.090 |
Why?
| | Emergency Medical Services | 1 | 2018 | 684 | 0.090 |
Why?
| | Hypoxia | 1 | 2019 | 1199 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2002 | 376 | 0.080 |
Why?
| | Gestational Age | 3 | 2025 | 990 | 0.080 |
Why?
| | Humans | 17 | 2025 | 145783 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2019 | 1151 | 0.080 |
Why?
| | Fetus | 4 | 2002 | 804 | 0.080 |
Why?
| | Laryngoscopy | 2 | 2022 | 121 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2025 | 17330 | 0.070 |
Why?
| | Nitric Oxide Synthase | 3 | 2002 | 234 | 0.060 |
Why?
| | Pregnancy | 5 | 2022 | 7216 | 0.060 |
Why?
| | Female | 11 | 2025 | 79045 | 0.060 |
Why?
| | Nitroarginine | 2 | 2002 | 57 | 0.060 |
Why?
| | Ductus Arteriosus | 2 | 2002 | 72 | 0.050 |
Why?
| | North America | 1 | 2025 | 304 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 8078 | 0.050 |
Why?
| | Neonatologists | 1 | 2023 | 11 | 0.050 |
Why?
| | Vascular Resistance | 2 | 2001 | 370 | 0.050 |
Why?
| | Infant | 3 | 2023 | 10091 | 0.050 |
Why?
| | Parturition | 1 | 2022 | 69 | 0.040 |
Why?
| | Meclofenamic Acid | 1 | 2001 | 9 | 0.040 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2001 | 18 | 0.040 |
Why?
| | Male | 7 | 2025 | 73011 | 0.040 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 76 | 0.040 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2001 | 82 | 0.040 |
Why?
| | Uterus | 1 | 2002 | 228 | 0.040 |
Why?
| | Fetoscopy | 1 | 2020 | 33 | 0.040 |
Why?
| | Drug Interactions | 1 | 2001 | 405 | 0.040 |
Why?
| | Endothelins | 1 | 2000 | 61 | 0.040 |
Why?
| | Oximetry | 1 | 2021 | 125 | 0.040 |
Why?
| | Meningomyelocele | 1 | 2020 | 62 | 0.040 |
Why?
| | Carbon Monoxide | 1 | 2000 | 82 | 0.040 |
Why?
| | Premedication | 1 | 2019 | 45 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2001 | 494 | 0.040 |
Why?
| | Educational Status | 1 | 2021 | 470 | 0.040 |
Why?
| | Airway Management | 1 | 2019 | 81 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 198 | 0.030 |
Why?
| | Prenatal Care | 1 | 2020 | 309 | 0.030 |
Why?
| | Blood Pressure | 2 | 2001 | 1782 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2021 | 554 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2002 | 1512 | 0.030 |
Why?
| | Child | 3 | 2022 | 22740 | 0.030 |
Why?
| | Patient Discharge | 1 | 2023 | 995 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2139 | 0.030 |
Why?
| | Infant, Premature | 1 | 2019 | 620 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1925 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7134 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 2 | 2002 | 78 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2002 | 203 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2934 | 0.020 |
Why?
| | United States | 2 | 2019 | 16126 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2002 | 1957 | 0.020 |
Why?
| | Quality Improvement | 1 | 2019 | 1296 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2002 | 552 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1372 | 0.020 |
Why?
| | Animals | 5 | 2002 | 38102 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2002 | 1723 | 0.020 |
Why?
| | Pulmonary Artery | 2 | 2002 | 1129 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11794 | 0.010 |
Why?
| | Chromones | 1 | 2002 | 43 | 0.010 |
Why?
| | Ligation | 1 | 2002 | 91 | 0.010 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 109 | 0.010 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2002 | 85 | 0.010 |
Why?
| | Morpholines | 1 | 2002 | 130 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2002 | 153 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2002 | 762 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2002 | 383 | 0.010 |
Why?
| | Injections, Intra-Arterial | 1 | 2000 | 26 | 0.010 |
Why?
| | Protoporphyrins | 1 | 2000 | 16 | 0.010 |
Why?
| | Receptor, Endothelin B | 1 | 2000 | 43 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 93 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 203 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 2000 | 60 | 0.010 |
Why?
| | Receptors, Endothelin | 1 | 2000 | 48 | 0.010 |
Why?
| | Protein Precursors | 1 | 2000 | 136 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1368 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 821 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2000 | 571 | 0.010 |
Why?
| | Endothelin-1 | 1 | 2000 | 181 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 910 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2000 | 2805 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4568 | 0.010 |
Why?
|
|
Zenge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|